Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Pehamberger

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
Perspectives of pegylated interferon use in dermatological oncologyHubert Pehamberger
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 2, 2009
[Austrian Society for Dermatology and Venereology OGDV]Rainer Kunstfeld, Hubert Pehamberger
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2008
[Austrian Society for Dermatology and Venereology OGDV]]Hubert Pehamberger, Sekretär Kunstfeld
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 20, 2012
Trends in the diagnosis of melanoma at a university center over timePhilipp Tschandl, Hubert Pehamberger, Harald Kittler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 30, 2015
[Not Available]Georg Stingl, Werner Aberer, Hubert Pehamberger, et al.
Archives of Dermatology|June 19, 2008
Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?Martin Stichenwirth, Elisabeth Riedl, Hubert Pehamberger, et al.
Pigment Cell & Melanoma Research|December 8, 2011
Site-dependent actinic skin damage as risk factor for melanoma in a central European populationJudith Wendt, Oliver Schanab, Michael Binder, et al.
American Journal of Clinical Dermatology|June 1, 2006
Management of refractory early-stage cutaneous T-cell lymphomaMargit A Huber, Gyde Staib, Hubert Pehamberger, et al.
Wiener Klinische Wochenschrift|January 18, 2006
[Guidelines for the planning and implementation of telemedical applications]Georg Duftschmid, Michael Binder, Thomas Wrba, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2005
[Clinical value of a dermatoscopic classification of Clark nevi]Ligia Teban, Hubert Pehamberger, Klaus Wolff, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
Perspectives of pegylated interferon use in dermatological oncologyHubert Pehamberger
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 2, 2009
[Austrian Society for Dermatology and Venereology OGDV]Rainer Kunstfeld, Hubert Pehamberger
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2008
[Austrian Society for Dermatology and Venereology OGDV]]Hubert Pehamberger, Sekretär Kunstfeld
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 20, 2012
Trends in the diagnosis of melanoma at a university center over timePhilipp Tschandl, Hubert Pehamberger, Harald Kittler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 30, 2015
[Not Available]Georg Stingl, Werner Aberer, Hubert Pehamberger, et al.
Archives of Dermatology|June 19, 2008
Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?Martin Stichenwirth, Elisabeth Riedl, Hubert Pehamberger, et al.
Pigment Cell & Melanoma Research|December 8, 2011
Site-dependent actinic skin damage as risk factor for melanoma in a central European populationJudith Wendt, Oliver Schanab, Michael Binder, et al.
American Journal of Clinical Dermatology|June 1, 2006
Management of refractory early-stage cutaneous T-cell lymphomaMargit A Huber, Gyde Staib, Hubert Pehamberger, et al.
Wiener Klinische Wochenschrift|January 18, 2006
[Guidelines for the planning and implementation of telemedical applications]Georg Duftschmid, Michael Binder, Thomas Wrba, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2005
[Clinical value of a dermatoscopic classification of Clark nevi]Ligia Teban, Hubert Pehamberger, Klaus Wolff, et al.
Pageof 12